Rabin Shrestha, MD
Pulmonary Disease · Memphis, TNNPI 1164697926
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (42.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 66.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $4,073, 9.2 times the $441 reported in 2019.
Across 39 payments — averaging $152.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Jazz Pharmaceuticals Inc.$486
- United Therapeutics Corporation$431
- Boehringer Ingelheim$350
- ZOLL Respicardia, Inc.$174
- AstraZeneca$147
- plus $427 from 9 others
What the payments were for
- Travel & lodging$1,36423%
- Food & beverage$2,08435%
- Education$2,50042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $3,932 |
| Jazz Pharmaceuticals Inc. | 4 | $486 |
| United Therapeutics Corporation | 9 | $431 |
| Boehringer Ingelheim | 4 | $350 |
| ZOLL Respicardia, Inc. | 1 | $174 |
| AstraZeneca | 2 | $147 |
| Genentech USA, Inc. | 1 | $140 |
| Harmony Biosciences LLC | 1 | $121 |
| Gilead | 1 | $34 |
| Johnson & Johnson | 1 | $28 |
| Edwards Lifesciences | 1 | $25 |
| CSL Behring | 1 | $25 |
| GSK | 1 | $24 |
| Ambu Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,834
- OFEV$230
- TYVASO$218
- remede System$174
- BREZTRI$125
- Wakix$121
- XYWAV$117
How this compares
$5,948 in reported general payments places this provider in the 60th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Memphis
- Andrew HoltMemphis$69K
- Dipen KadariaMemphis$31K
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
- Aaron MilstoneFranklin$482K
- Otis RickmanNashville$392K
- Michael CzarneckiChattanooga$348K
- Susan GarwoodNashville$343K
- Girendra HoskereBristol$285K
- Carlos BaleeiroChattanooga$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.